Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology
Go back to Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 68.99 +0.44 (0.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.55 | 52 Week High | $18.39 | |||
| Open | $69.34 | 52 Week Low | $6.96 | |||
| Day High | $69.81 | P/E | N/A | |||
| Day Low | $68.27 | EPS | $-0.58 | |||
| Volume | 1,054,256 | |||||
| (NASDAQ: ORKA) | Delayed: 85.38 +13.04 (18.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.34 | 52 Week High | $ | |||
| Open | $81.00 | 52 Week Low | $ | |||
| Day High | $88.83 | P/E | N/A | |||
| Day Low | $79.00 | EPS | $ | |||
| Volume | 4,201,124 | |||||
